HNRNPL and coronary artery disorder: Qiet al. [7] proposed a CHD assessment method by detecting plasmainflammatory cytokines, which showed that tumor necrosis factor (TNF) and heterogenous nuclear ribonucleoprotein L (hnRNPL) related immunoregulatorylong non-coding RNA (THRIL) was increased in CHD patients and can beused to predict CHD risk.